Recombinant vaccine-derived polioviruses in healthy children, Madagascar

Emerging Infectious Diseases

Volumn 19, Issue 6, 2013, Pages 1008-1010

  Razafindratsimandresy, Richter ^a   Joffret, Marie Line ^b,c   Rabemanantsoa, Sendraharimanana ^a   Andriamamonjy, Seta ^a   Heraud, Jean Michel ^a   Delpeyroux, Francis ^b,c  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b INSTITUT PASTEUR   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; ORAL POLIOMYELITIS VACCINE; RECOMBINANT VACCINE; CAPSID PROTEIN; VP1 PROTEIN, POLIOVIRUS;

CHILD; CYTOPATHOGENIC EFFECT; FECES ANALYSIS; FLACCID PARALYSIS; GENETIC DRIFT; HUMAN; LETTER; MADAGASCAR; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLIOMYELITIS; POLIOMYELITIS VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIRUS STRAIN; CLASSIFICATION; EPIDEMIC; GENETICS; IMMUNOLOGY; INFANT; PHYLOGENY; PRESCHOOL CHILD; RECOMBINANT; REEMERGENCE; VACCINE COVERAGE; VACCINE-DERIVED POLIOVIRUSES; VIRUS;

MADAGASCAR; POLIOVIRUS; RECOMBINANT; REEMERGENCE; VACCINE COVERAGE; VACCINE-DERIVED POLIOVIRUSES; VIRUSES;

CAPSID PROTEINS; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFANT; MADAGASCAR; PHYLOGENY; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL;

EID: 84877991551     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1906.130080     Document Type: Letter

References (10)

1. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccinederived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587-635. http://dx.doi.org/10.1146/annurev.micro.58.030603.123625
2. Rakoto-Andrianarivelo M, Gumede N, Jegouic S, Balanant J, Andriamamonjy SN, Rabemanantsoa S, et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis. 2008;197:1427-35 http://dx.doi.org/10.1086/587694.
3. Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, Balanant J, et al. Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis. 2003;9:885-7. http://dx.doi.org/10.3201/eid0907.020692
4. Rakoto-Andrianarivelo M, Guillot S, Iber J, Balanant J, Blondel B, Riquet F, et al. Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar. PLoS Pathog. 2007;3:e191. http://dx.doi.org/10.1371/journal.ppat.0030191
5. Joffret ML, Jegouic S, Bessaud M, Balanant J, Tran C, Caro V, et al. Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children. J Infect Dis. 2012;205:1363-73 http://dx.doi.org/10.1093/infdis/jis204.
6. Department of Immunization, Vaccines and Biologicals, World Health Organization. Isolation and identification of polioviruses. In: Polio laboratory manual. 4th edition. WHO/IVB/04.10.2004. p. 87-100 [cited 2013 Apr 11]. http://who.int/vaccines/en/poliolab/WHO-Polio-Manual-9.pdf
7. Kilpatrick DR, Nottay B, Yang CF, Yang SJ, Mulders MN, Holloway BP, et al. Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol. 1996;34:2990-6.
8. Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, Almond JW, et al. Genetic basis of attenuation of the Sabin type-2 vaccine strain of poliovirus in primates. Virology. 1993;192:18-26. http://dx.doi.org/10.1006/viro.1993.1003
9. Centers for Disease Control and Prevention. Update on vaccine-derived polioviruses-worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep. 2012;61:741-6.
10. Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, et al. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol. 2013 Feb 13. [Epub ahead of print]. http://dx.doi.org/10.1128/JVI.02954-12